We use cookies to provide visitors of our website with the best possible experience. To learn more how we use cookies or how to block cookies, please visit our cookie policy.

Resources - Scientific Posters

Validation of Th17 Cell Differentiation from Peripheral Blood CD4+ Cells through Assessment of mRNA


Related Products: Cytation 1, Cytation 5

February 03, 2016

Authors: Brad Larson, BioTek Instruments, Inc. Winooski, VT USA; Annegret Taubner, Miltenyi Biotec, Inc. Auburn, CA USA; Dylan Malayter, Affymetrix, Inc. Santa Clara, CA USA; Hilary Sherman, Corning Life Sciences, Kennebunk, ME USA

Miltenyl Biotec     Affymetrix     Corning


CD4+ T cells signal and regulate an immune response to pathogens after interacting with an antigen-MHC (major histocompatibility complex). This activation causes the cells to differentiate into distinct phenotypic and functional effectors, collectively referred to as T helper cells (Th), depending on specific cytokine signaling and transcription factors and epigenetic modifications. One such differentiated T cell subset are the pro-inflammatory T helper 17 (Th17) cells. These cells can be beneficial to the host during infection, as they amplify ongoing inflammation by inducing expression of tumor necrosis factor-α (TNF-α). However, uncontrolled activation of Th17 cells are associated with multiple inflammatory and autoimmune disorders including arthritis, primary Sjögren’s syndrome (pSS), multiple sclerosis (MS), and cancer. Naïve CD4+ T cells that are stimulated into Th17 differentiation are uniquely characterized by production of the pro-inflammatory cytokine, IL-17. Research has shown that targeting the IL-17 pathway has attenuated disease severity in preclinical models of autoimmune diseases, which has caused a growing interest in their use as a potential therapeutic target.

The process of attaining viable Th17 cells typically includes multiple steps. CD4+ T cells are isolated from peripheral blood mononuclear cells (PBMCs) and further selected against CD4. Purified cells are then differentiated into Th17 cells using a cocktail of specific antibodies and cytokines. The entire procedure to create and confirm this differentiation can be labor and time intensive.

Here we demonstrate a validated, robust method to differentiate cryopreserved peripheral blood CD4+ T cells into functional Th17 cells using a bead-based activation technology. A novel cell imaging multi-mode reader is used to image phenotypic differences between cells exposed to the antibody/ cytokine cocktail and negative control cells as differentiation proceeds. Creation of fully functioning Th17 cells was then confirmed by assessing IL-17F mRNA levels using a fluorescence RNA in situ hybridization (RNA FiSH) assay, in addition to IL-17 secretion using a homogeneous, bead-based immunoassay technology. The reader previously described performed all brightfield and fluorescence imaging steps, as well as laser-based excitation for the secretion immunoassay. The combination provides a comprehensive solution for the creation and validation of this important class of helper CD4+ T cells.

Cytation 5
Cytation™ 5 Cell Imaging Multi-Mode Reader